Genomic imprinting is a biological phenomenon determined by an evolutionally acquired, underlying system that may control harmonious development and growth in mammals. It is also relevant to some genetic disorders in man. In this article, lines of biological evidence of imprinting, characteristics of the mouse and human imprinted genes, and findings and mechanisms on the occurrence of several human imprinting disorders are reviewed.
gynogenote consisting of two copies of the maternal genome, has only the embryonic tissue lacking the placenta. Similar findings came from pronucleus transplantation experiments in the mouse. In androgenotes of this species, development of the placenta and yolk sac is nearly normal but that of the embryo is very poor, and reverse results are observed in the gynogenote (Cattanach, 1991) . These findings indicate that the parental alleles are differentially expressed in early mammalian development and both alleles are absolutely necessary for normal development.
A status that both homologous chromosomes are inherited from a parent is called uniparental disomy (UPD). The mouse with UPD for a given chromosome segment is made by mating between a parent who has a duplication of the segment and the other parent lacking the same segment. Since a gene dose in such a UPD mouse is not different from that in the wild-type mouse, a phenotype would not be different between the two. However, this complementation rule is not applied to several chromosomal regions. For example, maternal UPD mice for a proximal region of mouse chromosome 11 show growth deficiency, while paternal UPD mice for the same region represent overgrowth (Cattanach and Kirk, 1985) . The maternal UPD mouse for a distal region of chromosome 7 shows lethal growth deficiency, and the paternal UPD mouse dies at an earlier stage (Ferguson-Smith et al., 1991) . At least 10 imprinting regions from 6 different mouse chromosomes have been identified, and an imprinting map has been made (Cattanach, 1991) . in man, 9 (chromosomes 2, 6, 7, 11, 14, 15, 16, 20 , and X) of the 16 UPDs observed represent phenotypic effects (Ledbetter and Engel, 1995) (Table 1 ). The fact that some of these regions show homology to those in the mouse suggests that genomic imprinting is completely or partially conserved in the evolutional process.
More direct evidence for imprinting in the mouse was provided by experiments with hairpin tail mice, T hr. A half of the offspring of a T hp mother are lethal, while those of a T hp father have a hairpin-like short tail. This "T-associated maternal effect, Trne" is caused by a DNA deletion on chromosome 17 (Barlow et al., 1991) . It was suggested that the presence of a maternal copy of Tree is essential for normal development of the mouse embryo, namely, Tme is the maternally expressing locus and the paternal Tree copy is inactive in offspring.
Identification of Imprinted Genes
At least 14 imprinted genes have been identified in the mouse by means of a variety of searching methods (Table 1) . Transgenic mouse experiments contributed to the establishment of the concept of imprinting. Heterozygotes for a mutant insulin-like growth factor II gene (/g/'2) that is mapped to a distal imprinted region of mouse chromosome 7 showed growth deficiency when the mutant allele came from the father, while those whose mutant allele was derived from the mother represented normal growth, the result indicating that the mouse /if2 is a maternally imprinted (or paternally expressing) gene (DeChiara et al., 1991) . On the other hand, the gene for the receptor of Igf-II, Igf2r, was identified to be paternally imprinted, and this gene is responsible for ThP/Trne (Barlow et al., 1991) . Thus, /gf2 and Igf2r is reversely imprinted. Likewise, a maternally expressing gene, H19 (Bartolomei et al., 1991) , and a paternally expressing gene, Snrpn (the small nuclear ribonucleoprotein polypeptide N gene) (Left et al., 1992) , were isolated from the mouse chromosome 7. H19 is highly expressed in the mesoderm and extraembryonic tissues. It is most likely that H19 plays an important role in the fetal growth and has a tumor suppressor potential. Snrpn was isolated from a mouse imprinting region that corresponds to the human Prader-Willi syndrome critical region (PWCR). Searching in an Igf2-H19 imprinting gene cluster in the mouse genome, two more imprinted genes were identified: the insuln II gene (Ins2) and its retroposon, Insl. These insulin genes are expressed biallelically (not imprinted) in the pancreas, but paternal monoallelic expression was evident in the yolk sac (Giddings et al., 1994) . The mouse homolog (Mash2) of the Drosophila achaete-scute gene, Ascl2, which encodes a transcription factor, is maternally expressed in the trophoblast cell and preimplantation zygote, and thus it is considered to be essential for the development of trophoblasts (Guillemot et al., 1995) . Iff2, H19, Ins2, Mash2, Snrpn, ZNF127, and another imprinted gene, p57 raP2, are all located on the mouse chromosome 7. With the restriction landmark genome scanning (RLGS) method, the paternally expressed mouse gene, SP2 (U2aJbp-rs), was isolated (Hatada et al., 1993; Hayashizaki et al., 1994) , assigned to an imprinting region of chromosome 11, and possibly plays a role in the determination of body size. Another approach, a screening of the genome by means of the subtraction hybridization method made it possible to isolate two novel mouse paternally expressed genes: Pegl (paternally expressed gene 1), which was mapped to chromosome 6 (Kaneko-Ishino et aL, 1995) , and the other, Peg3, mapped to the proximal region of chromosome 7 (Kuroiwa et aL, 1996) . Until now, 4 mouse maternally expressing genes, lgf2r, H19, Mash2 and p57 ~w2 (Hatada and Mukai, 1995) , and 10 paternally expressing genes, Mas, Igf2, Ins2, Snrpn, Zuf127, Peg3, Pegl, lnsl, CDC25Mm and SP2 have been identified (Table 1) .
Human imprinted genes were also identified either independently or by utilizing homology to the mouse imprinted genes (Table 1) . Although IGF2, H19, SNRPN and p57 ~P2 (Hatada et al., 1996a) were confirmed to be imprinted as are their mouse homologs, INS has been shown to be expressed biallelically. Searching around the SNRPN region identified 4 novel imprinted genes, ZNF127, PAR5, PAR1 and IPW (Sutcliffe et al., 1994; Wevrick et al., 1994) , all expressing paternally. The human Wilms tumor gene, WT1, shows an imprinting polymorphism in the placenta, i.e., there are two populations, one with maternal monoallelic expression and the other with biallelic expression (Jinno et al., 1994) . The expression of the human HI9 is biallelic in the placenta before 9 weeks of pregnancy, but maternal monoallelic expression is observed after 10 weeks, indicating that the human HI9 imprinting depends upon developmental stages (Jinno et aL, 1995) . Because of the difficulty of observations of gene expression in an early human development, it has not yet been confirmed whether other genes are imprinted in man.
Genomic Imprinting-Related Genetic Diseases Prader-Willi syndrome (PWS) and Angelman syndrome (AS).
PWS is a neurogenetic disorder characterized by severe muscular hypotonia in early infancy, hypopigmentation of the skin, hypogonadism, hyperphagia and subsequent obesity, and mental retardation. AS is another disorder characterized by severe mental retardation, epilepsy, ataxic gait, and paroxysmal laughter. Each disorder occurs in about 1/15,000 newborns. A majority (73%) of PWS patients have a deletion at the ql 1-q13 region on the paternally-derived chromosome 15 [del(15)(qll.lql3)pat] and 25% maternal UPD for the chromosome [upd(15)mat], while 73% of AS patients have a deletion at the same region on the maternally-derived chromosome and 2% paternal UPD for chromosome 15 (Fig. 1) . This finding is the analogy of the above mentioned "maternal effect, Tree" in Tap. Normally, PWCR is a paternally expressed domain, and when the function of gene(s) in the domain is lost, PWS may occur. On the other hand, the Angelman syndrome critical region (ASCR) is a maternally expressed region, of which "loss of function" may result in AS. By molecular studies, the smallest deletion overlap (SRO) responsible for PWS is estimated to be from D15S63 to D15SI74, to which several genes have 
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Genetic map of loci at 15qi 1-qi3 region. Loci with italic letters show differential methylation patterns between parental alleles. Box depicts the putative PWS and AS loci.
been assigned (Fig. 2) . SNRPN is one of them and may act in the nerve system during early development by participating in mRNA-splicing. Paternal monoallelic expression of SNRPN has been observed in the brain of normal fetuses, but no such expression is detected in PWS patients (Glenn et al., 1993) . In addition, a PWS patient who has t(15;19), a breakpoint of which is located within SNRPN, was recently found. From these characteristics, SNRPN is a strong candidate PWS gene. Similarly, in PAR5 which is located 50-kb downstream to SNRPN, paternal monoallelic expression is observed in the normal fetal tissues but no expression in PWS patients (Wevrick et al., 1994) . Two other transcripts, IPW and PARI, located 150-kb and 170-kb distal to SNRPN, respectively, are expressed only on the paternally derived chromosome. Methylation patterns specific for maternally and paternally derived chromosomes 15 are observed, i.e., the maternal alleles at the D15S9 (ZNF127) located 1-Mb proximal to SNRPN, D15S63 (PWT1) and the SNRPN loci are usually hypermethylated, and the paternal alleles at these loci remain undermetbylated. PWS patients with del(15)pat or upd(15)mat retain only Vol. 41, No. 4, 1996 the methylated maternal alleies, losing the active paternal loci (Driscoll et aL, t992; Dittrich et al., 1993) . There have been a few P W S / A S patients who have biparentally-derived chromosomes 15 but show abnormal methylation patterns. Both alleles at the D15S63 locus in such PWS patients showed maternal methylation patterns as if they came from the mother, and vice versa in AS patients. Similar results were obtained at the D15S9 locus. The abnormality in these patients is referred to as an imprinting mutation. Detailed study demonstrated that three such PWS patients with imprinting mutations actually had a minute deletion involving exon 1 of S N R P N (Buiting et aL, 1994; Sutcliffe et al., 1994; Dittrich et al., 1996) . On the other hand, 7 AS patients with an imprinting mutation had either a minute deletion or a base substitution at a region more proximal to SNRPN-exon 1. Novel alternative transcripts of S N R P N were identified from this region (Dittrich et al., 1996) . Imprinting mutations do not disturb the whole imprinting phenomenon but may specifically involve only the P W S / A S region. Minute deletions in PWS patients at exon 1 of S N R P N may cause a change of the methylation pattern at both D15S9 and D15S63 loci and involve the inactivation of the ZNF127, S N R P N , P A R 5 , I P W and PAR1 genes. Since these loci/genes are located within Fig. 3 . Microdeletions in PWS and AS patients with imprinting mutations (upper) and a model for reset of parental imprint (lower). Solid bars and triangle in the upper row depict microdeletions and a point mutation observed. The putative imprintor (IC) at the BD region may act as a suppressor for the putative imprint switch initiation site (SIS) at exon l of SNRPN. a 1.5-Mb extent, the imprinting may involve this 1.5-Mb domain. From these findings, a hypothesis was proposed: at this 5' region of SNRPN, there must be an imprinting center (IC) or imprintor which controls in a cis-acting manner a putative imprinting switch initiation site (SIS) located at exon 1 (Fig. 3) (Dittrich et aL, 1996) . Normally, in the female germline, the paternally-derived IC suppresses the SIS function, and therefore the paternal imprint would switch to that for the maternal chromosome by a trans-acting factor in the germ cell. On the other hand, in the male germline, since IC on the maternally-derived chromosome is inactive, SIS would mark the chromosome with the paternal imprint. This model was successful to explain complex genetic findings on PWS./AS patients. In PWS patients, an imprinting mutation having occurred in a grandmother is transmitted to a father. Because the maternal imprint had normally occurred in the grandmother, the father is phenotypically normal. However, as the imprinting was not reset in his germ cells because of a lacking of SIS, the chromosome 15 retained the maternal imprint, PWS occurs in his child (Fig. 4) . The reverse is true in AS.
Beckwith-Wiedemann syndrom (BWS).
BWS is an overgrowth syndrome characterized by gigantism, macroglossia, exomphalos, hypoglycemia in infancy, and embryonal tumors including Wilms tumor. A linkage analysis in familial cases with an autosomal dominant mode of inheritance demonstrated a strong tinkage to DNA markers at chromosome 1tp15.5. Thus, the BWS locus was assigned to this region. Genetic findings of BWS are also complex and classified into the following four classes: (1) familial cases whose disorders are all derived through females; (2) translocation cases with breakpoints at 1 l p15, all maternally derived; (3) t l p 15 duplications, all paternally derived; (4) paternal UPD involving Ilp15.5 observed in some karyotypically normal patients. To explain the above four findings, a hypothesis was proposed (Mannens et al., 1994) : in the l lp15 region, there must be the paternally expressed BWS locus (BI4/) and the maternally expressed control locus (CL) that suppressively control B W (Fig. 5) . In normal individuals, as B W and CL are reversely imprinted, only the maternal CL allele and only the paternal B W allele are expressed, but in BWS patients with both trisomy for l lp15 and paternal UPD have two copies of B W , resulting in overgrowth. In both familial or translocation cases, biparental BW-alleles are expressed because of a mutation in CL. A candidate gene for BI4 / is human IGF2 that encodes a growth factor in the fetus, and its over expression may result not only in overgrowth and hypoglycemia but also in tumors. Imprinting of the mouse Igf2 and the human IGF2 have been proven, both showing paternal monoallelic expression. Biallelic expression of IGF2 was also confirmed in the skin fibroblasts and the tongue of BWS patients (Weksberg et al., 1993) , and also in Wilms tumor tissue (Ogawa et al., 1993) . One of the candidate for CL is the p57 K1e2 gene which is maternally expressed (Hatada et al., I996a) . The p57 K~e2 protein is a potent tight-binding inhibitor of several GI cyclin/Cdk complexes and is a negative regulator of cell proliferation. Hatada et al. (1996b; unpublished data) recently demonstrated that a nonsense mutation in the p57 K~e~ gene was identified in 4 of 15 familial or sporadic BWS patients analyzed. Furthermore, in one family, the phenotypically normal mother had the same mutation as the patient. The findings are well consistent with the maternal transmission of mutations in familial BWS cases and with the characteristic of CL in the previous model. Furhter studied are required how this gene interacts with
IGF2.

Prospects
Genomic imprinting may play a role in the occurrence of other genetic disorders. They are listed in Table 2 , in which an inheritance mode cannot well be explained by formal genetics. Observations of UPD in human chromosomes may also provide suggestive evidence of imprinting, Le., recent studies demonstrated with the same mutation LOI of maternal IGF2 allele/LOH of maternal allele LOH of maternal allele t(9pat;22mat) paternal transmission androgenesis/development of placenta gynogenesis/development of fetal tissues extra paternal copy/overgrowth of placenta frequent maternal transmission frequent maternal transmission frequent paternal transmission UD7MA UD9MA UD14MA/UD14PA UD14MB that imprinting is relevant to Silver-Russell syndrome (Kotzot et al., 1995) and myeloid leukemia in a patient with yon Recklinghausen disease (Stephens et aL, 1996) . Thus, it is of great interest not only to find new imprinting disorders but to dissect the mechanisms of genomic imprinting, especially how the primary imprint is determined and why this phenomenon exists in the mammals.
